The effects of isoliquiritigenin on endometriosis in vivo and in vitro study
- PMID: 32736296
- DOI: 10.1016/j.phymed.2020.153214
The effects of isoliquiritigenin on endometriosis in vivo and in vitro study
Abstract
Background: Endometriosis is a common gynaecological disease characterized by growth of uterine endometrial tissue, outside the uterine cavity, on the ovaries, oviduct and pelvic peritoneum. Isoliquiritigenin (ISL) is a natural flavonoid isolated from the root of licorice (Glycyrrhiza uralensis) and shallot (Allium cepa). ISL has previously shown antioxidant, anti-inflammatory, anti-proliferation and anti-tumor activities.
Purpose: This study aimed to investigate the effects of ISL on endometriosis in vivo and in vitro.
Methods: End1/E6E7 endometriosis cells were treated with ISL and β-estradiol. The MTT assay was used to detect cell viability. Cell migration was evaluated by the wound-healing assay. The expression of epithelial-to-mesenchymal transition (EMT)-related proteins were detected by western blot. Female Balb/c mice, surgically induced to have endometriosis by transplanting uterine tissue into the abdominal cavity, were treated with ISL or vehicle for 4 weeks. Lesion growth was subsequently analyzed by high-resolution ultrasound imaging. Serum and lesion inflammatory cytokines were measured by ELISA. EMT-related proteins and apoptosis-related proteins of endometriotic lesions were detected by western blot.
Results: It was observed that ISL treatment inhibited the viability and migration of End1/E6E7. ISL treatment increased the expression of E-cadherin, and decreased the expression of N-cadherin, Slug and Snail. In the animal model, ISL treatment reduced the volume and weight of endometriotic lesions, decreased serum and lesion inflammatory cytokines, inhibited EMT, and induced apoptosis of the lesions.
Conclusion: ISL inhibited the viability, migration and EMT-related proteins of End1/E6E7 cells, reduced the volume and weight of endometriotic lesions, inhibited inflammatory cytokines and EMT, and induced apoptosis of the lesions to improve endometriosis.
Keywords: Endometriosis; Epithelial-mesenchymal transition; Inflammatory; Isoliquiritigenin.
Copyright © 2020 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest We confirm that there are no known conflicts of interest associated with this publication and that there has been no significant financial support for this work that could have influenced the outcome.
Similar articles
-
Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition.Molecules. 2019 Oct 16;24(20):3725. doi: 10.3390/molecules24203725. Molecules. 2019. PMID: 31623144 Free PMC article.
-
The Potential Effect of Fucoidan on Inhibiting Epithelial-to-Mesenchymal Transition, Proliferation, and Increase in Apoptosis for Endometriosis Treatment: In Vivo and In Vitro Study.Biomedicines. 2020 Nov 22;8(11):528. doi: 10.3390/biomedicines8110528. Biomedicines. 2020. PMID: 33266505 Free PMC article.
-
Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway.Biosci Rep. 2020 Jan 31;40(1):BSR20192727. doi: 10.1042/BSR20192727. Biosci Rep. 2020. PMID: 31840737 Free PMC article.
-
Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases.J Ethnopharmacol. 2024 Jan 10;318(Pt B):117059. doi: 10.1016/j.jep.2023.117059. Epub 2023 Aug 20. J Ethnopharmacol. 2024. PMID: 37604329 Review.
-
Surveying the Therapeutic Potentials of Isoliquiritigenin (ISL): A Comprehensive Review.Chem Biodivers. 2025 Apr 24:e202500456. doi: 10.1002/cbdv.202500456. Online ahead of print. Chem Biodivers. 2025. PMID: 40274535 Review.
Cited by
-
Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis.Int J Mol Sci. 2023 Jul 30;24(15):12195. doi: 10.3390/ijms241512195. Int J Mol Sci. 2023. PMID: 37569571 Free PMC article. Review.
-
Isoliquiritigenin attenuates pathological cardiac hypertrophy via regulating AMPKα in vivo and in vitro.J Mol Histol. 2022 Aug;53(4):679-689. doi: 10.1007/s10735-022-10090-w. Epub 2022 Jul 14. J Mol Histol. 2022. PMID: 35834120
-
Emerging Drug Targets for Endometriosis.Biomolecules. 2022 Nov 8;12(11):1654. doi: 10.3390/biom12111654. Biomolecules. 2022. PMID: 36359004 Free PMC article. Review.
-
Unlocking the Potential: How Flavonoids Affect Angiogenesis, Oxidative Stress, Inflammation, Proliferation, Invasion, and Alter Receptor Interactions in Endometriosis.Food Sci Nutr. 2024 Dec 7;13(1):e4607. doi: 10.1002/fsn3.4607. eCollection 2025 Jan. Food Sci Nutr. 2024. PMID: 39803270 Free PMC article. Review.
-
Therapeutic Potential of Natural Resources Against Endometriosis: Current Advances and Future Perspectives.Drug Des Devel Ther. 2024 Aug 21;18:3667-3696. doi: 10.2147/DDDT.S464910. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39188919 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous